Avoro Capital Advisors LLC
CIK: 0001633313
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Whitehawk Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (1 total)
- May 12, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)IndirectPre-funded Warrant (right to buy)
6.4M shares at avg. $3.92-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 12, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Pre-funded Warrant (right to buy) | 6,377,714 | $3.92 | - | Indirect |
1-1 of 1 transactions
About Avoro Capital Advisors LLC
Avoro Capital Advisors LLC (SEC CIK 0001633313) files insider reports with the SEC as Director of Whitehawk Therapeutics, Inc. (WHWK).
Signal8 holds 1 ownership filing by Avoro Capital Advisors LLC, a Form 4, filed on May 14, 2026. Those filings report 1 transaction, the latest on May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Avoro Capital Advisors LLC's filings is in NEW YORK, NY.
Recent filings by Avoro Capital Advisors LLC
- May 12, 2026: Grant or award of WHWK derivative securities (Form 4, code A).
Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)
- Giacobello Scott M., CHIEF FINANCIAL OFFICER
- BALL BRYAN
- Dornan David, Chief Scientific Officer
- Lennon David James, CHIEF EXECUTIVE OFFICER
- Dugan Margaret, Chief Medical Officer
- Iyengar Vijay K, Director